Literature DB >> 8977305

CD40-mediated stimulation of B1 and B2 cells: implication in autoantibody production in murine lupus.

Y Kaneko1, S Hirose, M Abe, H Yagita, K Okumura, T Shirai.   

Abstract

B1 cells usually show preferential responses to T cell-independent antigens. To ask whether B1 cells could respond to CD40-mediated stimulation for proliferation and differentiation, and whether CD40-mediated signals are involved in the production of autoantibodies by B1 cells, we compared responses to our newly established agonistic anti-mouse CD40 monoclonal antibody (mAb) between B1 and B2 cells from autoimmune-prone (NZB x NZW) F1 mice. Stimulation with this mAb induced a similar level of proliferative responses of both B1 and B2 cells, as well as an increase in expression of cell surface molecules I-A, CD54, CD23, CD80, and CD86. While co-stimulation with interleukin (IL)-4 markedly augmented proliferative as well as IgG1 and IgE antibody responses of both B and B2 cells, co-stimulation with IL-5 augmented proliferative and IgM antibody responses of only B1 cells. Splenic B1, but not B2 cells from young (NZB x NZW) F1 mice spontaneously produced substantial amounts of IgM including IgM anti-DNA antibodies, and the levels increased in case of stimulation with anti-CD40 mAb alone, or to a greater extent with the mAb plus IL-4 and IL-5. Collectively, these results indicate that splenic B1 cells from autoimmune (NZB x NZW) F1 mice have a comparable responsiveness to the CD40-mediated stimulation to that of B2 cells, which would be a potent regulatory mechanism involved in the spontaneous production of autoantibodies by B1 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977305     DOI: 10.1002/eji.1830261236

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Role of the CD47-SHPS-1 system in regulation of cell migration.

Authors:  Sei-Ichiro Motegi; Hideki Okazawa; Hiroshi Ohnishi; Ryuji Sato; Yoriaki Kaneko; Hisae Kobayashi; Kyoko Tomizawa; Tomokazu Ito; Nakayuki Honma; Hans-Jörg Bühring; Osamu Ishikawa; Takashi Matozaki
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

Authors:  S Hirose; K Yan; M Abe; Y Jiang; Y Hamano; H Tsurui; T Shirai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease.

Authors:  Kiminori Kimura; Hisataka Moriwaki; Masahito Nagaki; Masanao Saio; Yasunari Nakamoto; Makoto Naito; Kazuo Kuwata; Francis V Chisari
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

5.  The soluble CD40 ligand sCD154 in systemic lupus erythematosus.

Authors:  K Kato; E Santana-Sahagún; L Z Rassenti; M H Weisman; N Tamura; S Kobayashi; H Hashimoto; T J Kipps
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

Authors:  Marshall D Behrens; Wolfgang M Wagner; Christopher J Krco; Courtney L Erskine; Kimberly R Kalli; James Krempski; Ekram A Gad; Mary L Disis; Keith L Knutson
Journal:  Blood       Date:  2007-11-20       Impact factor: 22.113

7.  Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice.

Authors:  J Gonzalez; S Saha; E Peeva
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

Review 8.  Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2010-08-17

Review 9.  The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?

Authors:  Marta Magatti; Alice Masserdotti; Anna Cargnoni; Andrea Papait; Francesca Romana Stefani; Antonietta Rosa Silini; Ornella Parolini
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

10.  CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells.

Authors:  Wojciech Dawicki; Hui Huang; Yanna Ma; Jennifer Town; Xiaobei Zhang; Chris D Rudulier; John R Gordon
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.